Patents by Inventor Mark W. Hankins

Mark W. Hankins has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200306341
    Abstract: A method of treating an eye disease comprising administering an adeno-associated virus (AAV) vector to a mammalian subject by subretinal injection, wherein the AAV vector comprises a nucleotide sequence encoding melanopsin operably linked to an expression control sequence to promote expression of melanopsin in cells of the eye of the subject.
    Type: Application
    Filed: January 9, 2020
    Publication date: October 1, 2020
    Inventors: Robert Maclaren, Alun R. Barnard, Samantha R. De Silva, Mark W. Hankins
  • Publication number: 20190282658
    Abstract: A method of treating an eye disease comprising administering an adeno-associated virus (AAV) vector to a mammalian subject by subretinal injection, wherein the AAV vector comprises a nucleotide sequence encoding melanopsin operably linked to an expression control sequence to promote expression of melanopsin in cells of the eye of the subject.
    Type: Application
    Filed: April 12, 2019
    Publication date: September 19, 2019
    Inventors: Robert MACLAREN, Alun R. BARNARD, Samantha R. DE SILVA, Mark W. HANKINS
  • Publication number: 20180360912
    Abstract: A method of treating an eye disease comprising administering an adeno-associated virus (AAV) vector to a mammalian subject by subretinal injection, wherein the AAV vector comprises a nucleotide sequence encoding melanopsin operably linked to an expression control sequence to promote expression of melanopsin in cells of the eye of the subject.
    Type: Application
    Filed: August 31, 2018
    Publication date: December 20, 2018
    Inventors: Robert MACLAREN, Alun R. BARNARD, Samantha R. DE SILVA, Mark W. HANKINS
  • Publication number: 20180042992
    Abstract: A method of treating an eye disease comprising administering an adeno-associated virus (AAV) vector to a mammalian subject by subretinal injection, wherein the AAV vector comprises a nucleotide sequence encoding melanopsin operably linked to an expression control sequence to promote expression of melanopsin in cells of the eye of the subject.
    Type: Application
    Filed: October 30, 2017
    Publication date: February 15, 2018
    Inventors: Robert MACLAREN, Alun R. BARNARD, Samantha R. DE SILVA, Mark W. HANKINS
  • Patent number: 9564111
    Abstract: A guitar support stand includes a mounting plate that is attachable to a stable support such as a musical piece of equipment having a substantial weight. A guitar support member is releasably attached to the mounting plate and includes at its upper end a support bracket for supporting the neck portion of a guitar.
    Type: Grant
    Filed: December 21, 2015
    Date of Patent: February 7, 2017
    Inventor: Mark W. Hankins
  • Publication number: 20160324921
    Abstract: A method of treating an eye disease comprising administering an adeno-associated virus (AAV) vector to a mammalian subject by subretinal injection, wherein the AAV vector comprises a nucleotide sequence encoding melanopsin operably linked to an expression control sequence to promote expression of melanopsin in cells of the eye of the subject.
    Type: Application
    Filed: May 5, 2015
    Publication date: November 10, 2016
    Applicant: ISIS INNOVATION LIMITED
    Inventors: Robert E. MacLaren, Alun R. Barnard, Samantha R. De Silva, Mark W. Hankins
  • Publication number: 20160111070
    Abstract: A guitar support stand includes a mounting plate that is attachable to a stable support such as a musical piece of equipment having a substantial weight. A guitar support member is releasably attached to the mounting plate and includes at its upper end a support bracket for supporting the neck portion of a guitar.
    Type: Application
    Filed: December 21, 2015
    Publication date: April 21, 2016
    Inventor: Mark W. Hankins
  • Publication number: 20090208462
    Abstract: The invention concerns the use of a nucleic acid encoding a photoactivator in the manufacture of a medicament for inducing photosensitivity in neuronal cells. In particular, the invention concerns the induction of photosensitivity in retinal ganglion cells (RGCs) for restoring sight and/or alleviating blindness in an individual. The invention further concerns vectors, cells and pharmaceutical compositions therefor.
    Type: Application
    Filed: November 29, 2005
    Publication date: August 20, 2009
    Applicant: IMPERIAL INNOVATIONS LIMITED
    Inventors: Mark W. Hankins, Robert Lucas